1.Analysis of Underlying Targets and Mechanism of Ginseng Radix et Rhizoma-Astragali Radix Treatment in Lung Cancer Based on Network Pharmacology
Zheng LI ; Xie-yu ZHANG ; Zi-ang YAO ; Wei HOU
Chinese Journal of Experimental Traditional Medical Formulae 2020;26(4):207-213
Objective::To analyze the potential targets and mechanism of Ginseng Radix et Rhizoma-Astragali Radix treatment in lung cancer based on network pharmacology. Method::The Ginseng Radix et Rhizoma, Astragali Radix ingredients and target genes were screened by the traditional Chinese medicine system pharmacology database and analysis platform (TCMSP). Lung cancer-related target genes were obtained from the human gene database (GeneCards). Cytoscape was used for constructing a " drug-ingredient-target-disease" network. Protein-to-protein interaction (PPI) data was downloaded from STRING and then PPI core genes was constructed by CentiScape. Gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis of key target genes was performed using R software. Result::A total of 17 Ginseng Radix et Rhizoma and 16 Astragali Radix ingredients were screened. 50 target genes of Astragali Radix and 95 target genes of Ginseng Radix et Rhizoma in the treatment of lung cancer were obtained. A " drug-ingredient-target-disease" network was constructed. 38 PPI core genes were screened using CentiScape. GO function enrichment showed that biological functions of Ginseng Radix et Rhizoma-Astragali Radix were concentrated in nuclear receptor function, transcription-related function, ubiquitination and apoptosis. KEGG pathway enrichment showed that Ginseng Radix et Rhizoma-Astragali Radix treatment in lung cancer were mainly involved in phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), apoptosis, tumor necrosis factor (TNF) and other pathways. Conclusion::By constructing a " drug-ingredient-target-disease" network, the mechanism of Ginseng Radix et Rhizoma-Astragali Radix treatment in lung cancer was discussed from the perspective of multi-component, multi-target and multi-pathway, which provides reference for further research.
2.Establishment of a novel mouse mode of elastase-induced chronic obstructive pulmonary disease related osteoporosis.
Wen-Xiang CHEN ; Yong-Li WANG ; Zi-Ang XIE ; Shun-Wu FAN ; Xue-Sheng JIANG
China Journal of Orthopaedics and Traumatology 2020;33(4):356-362
OBJECTIVE:
To establish and evaluate the model of chronic obstructive pulmonary disease (COPD) with osteoporosis induced by elastase in mice.
METHODS:
Twenty four healthy female 8-week-old C57BL / 6 mice (weighing about 18 g) were randomly divided into three groups. The control group was given intratracheal drip of normal saline, the experimental group 1 and the experimental group 2 were given intratracheal drip of elastase, the control group and the experimental group 1 were kept for 8 weeks and then killed, the experimental group 2 was kept for 12 weeks and then killed. HE staining was used to evaluate the histopathological changes of lung and tibia in the control and experimental groups. The levels of serum inflammatory factors and broncho alveolar lavage factors (BALF) were detected by ELISA. Micro CT was used to detect the bone mass related parameters of mouse femur. The expression of osteoclastic and osteogenic genes was detected by real-time fluorescence quantitative PCR.
RESULTS:
Lung histopathology showed that the structure of alveoli in the experimental group was disordered, the walls of alveoli became thin or broken, and the alveoli cavity expanded. IL-6 and TNF-α in BALF were significantly higher than those in control group (<0.001), while IL-1β and TNF-α in serum inflammatory factors were significantly higher than those in control group (<0.001). BV / TV(bone volume fraction), TB.Th(average bone trabecular thickness) and TB.N(average bone trabecular number) in the experimental group were significantly lower than those in the control group (<0.05), TB.Sp (average bone trabecular separation) and BS / BV (bone surface area fraction) in the experimental group were significantly higher than those in the control group (<0.01). Compared with the control group, the expression of osteoclast related marker genes increased in the experimental group (<0.05), but decreased in the experimental group(<0.05). The results of experiment 1 and experiment 2 were time-dependent.
CONCLUSION
In this study, elastase was used to construct a COPD model with osteoporosis successfully, which provides a suitable animal model for the future study of the pathogenesis of COPD with osteoporosis.
Animals
;
Bone Density
;
Female
;
Mice
;
Mice, Inbred C57BL
;
Osteoporosis
;
etiology
;
Pancreatic Elastase
;
Pulmonary Disease, Chronic Obstructive
;
complications
3.Vestibular incision subperiosteal tunnel access with connective tissue graft for the treatment of Miller classI and II gingival recession.
Ke Ang FAN ; Jin Sheng ZHONG ; Xiang Ying OUYANG ; Ying XIE ; Zi Yuan CHEN ; Shuang Ying ZHOU ; Yuan ZHANG
Journal of Peking University(Health Sciences) 2019;51(1):80-85
OBJECTIVE:
To evaluate the clinical outcomes of vestibular incision subperiosteal tunnel access (VISTA) with connective tissue graft (CTG) in the treatment of Miller classes I and II localized gingival recession.
METHODS:
Ten patients with 10 Miller classes I and II localized gingival recessions were enrolled in the study. All defects were equal to or above 2 mm in recession depth. All the patients received treatment with VISTA+CTG. Their clinical parameters, including recession depth (Rec), recession width (RW), keratinized tissue width (KT), clinical attachment loss (CAL), probing depth (PD) were recorded and compared before surgery and 6 months later. The mean root coverage (MRC) and complete root coverage (CRC) were calculated at the end of 6 months. A visual analogue scale (VAS) was used to estimate the patients' discomfort during the operation and during the 2 weeks post-operation. Patient-based aesthetic satisfaction 6 months after surgery was evaluated by a VAS.
RESULTS:
The mean Rec was (2.65±0.82) mm at baseline, and (0.35±0.58) mm after 6 months. The VISTA+CTG treatment resulted in an improvement of (2.30±0.98) mm in recession depth (P<0.001). MRC was 86.67%±21.94% and CRC reached 70% at the end of 6 months. KT increased (0.90±1.22) mm (P<0.05). Aesthetic satisfaction on the patients' level was 8.30 based on VAS (0=unsatisfied, 10=extremely satisfied). The patients' discomfort during the operation and 2 weeks post operation were 2.40 and 4.30 (0=no pain, 10=extreme pain). Furthermore, clinical outcomes showed no statistically significant difference between the gingival biotypes, and between the teeth positioned in maxillary and in mandibular.
CONCLUSION
VISTA+CTG could be an effective treatment for Miller classes I and II localized gingival recession. Clinical outcomes indicated decrease in recession depth and width, and increase in width of keratinized tissue. Patients suffered little pain during the operation and 2 weeks post-operation of healing and accessed good aesthetic satisfaction. VISTA+CTG could be an option for the treatment of Miller classes I and II localized gingival recession.
Connective Tissue
;
Gingiva
;
Gingival Recession
;
Gingivoplasty
;
Humans
;
Tooth Root
;
Treatment Outcome